Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuro-Oncology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/noq160PMID 21059755PMCID PMC3064620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression profiling of ependymomas unravels localization and tumor grade‐specific tumorigenesis

  2009cited by this paper
• Intracranial ependymoma: factors affecting outcome.

  2009cited by this paper
• Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.

  2009cited by this paper
• Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

  2009cited by this paper
• Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.

  2009influential reference
• Immunohistochemical Prognostic Markers in Intracranial Ependymomas: Systematic Review and Meta-Analysis

  2009cited by this paper
• Caveolin 1 Expression Independently Predicts Shorter Survival in Oligodendrogliomas

  2009cited by this paper
• Caveolin-1 regulates EGFR signalling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition

  2009cited by this paper
• Caveats of caveolin-1 in cancer progression.

  2008cited by this paper
• Caveolin-1 in tumor progression: the good, the bad and the ugly

  2008cited by this paper
• Supratentorial ependymomas: Prognostic factors and outcome analysis in a retrospective series of 46 adult patients

  2008cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection.

  2007cited by this paper
• Caveolin-1 Expression is Variably Displayed in Astroglial-derived Tumors and Absent in Oligodendrogliomas: Concrete Premises for a New Reliable Diagnostic Marker in Gliomas

  2007cited by this paper
• Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas

  2006cited by this paper
• Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma

  2006cited by this paper
• Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

  2006cited by this paper
• Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Epidermal Growth Factor Receptor Exposed to Oxidative Stress Undergoes Src- and Caveolin-1-dependent Perinuclear Trafficking*

  2006cited by this paper
• Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas

  2006cited by this paper
• Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

  2005cited by this paper
• Supratentorial extraventricular ependymal neoplasms

  2005cited by this paper
• Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence

  2005cited by this paper
• A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma

  2004cited by this paper
• Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.

  2004cited by this paper
• Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae

  2004influential reference
• Proliferation- and Apoptosis-related Proteins in Intracranial Ependymomas: An Immunohistochemical Analysis

  2004cited by this paper
• Pediatric Intracranial Ependymomas: Prognostic Relevance of Histological, Immunohistochemical, and Flow Cytometric Factors

  2003cited by this paper
• Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

  2003cited by this paper
• Ependymal tumors

  2003cited by this paper
• Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

  2002cited by this paper
• Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

  2001cited by this paper
• Prognostic factors in intracranial ependymomas in children.

  2000cited by this paper
• Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.

  1999cited by this paper
• Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.

  1998cited by this paper
• Ependymomas: MIB-1 proliferation index and survival

  1998cited by this paper
• Genetic alterations in hormone-refractory recurrent prostate carcinomas.

  1998cited by this paper
• Cellular functions regulated by Src family kinases.

  1997cited by this paper
• Use of Human Tissues in Research: Clarifying Clinician and Researcher Roles and Information Flows

  1997cited by this paper
• The clinical and prognostic relevance of grading in intracranial ependymomas.

  1997cited by this paper
• Intracranial ependymoma in children: analysis of prognostic factors

  1992cited by this paper
• Infratentorial ependymomas in childhood: prognostic factors and treatment.

  1990cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis

  2025cites this paper
• Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design

  2024influential citation
• The biology of ependymomas and emerging novel therapies

  2022cites this paper
• The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study

  2021cites this paper
• Caveolin-1 expression predicts favourable outcome and correlates with PDGFRA mutations in gastrointestinal stromal tumours (GISTs)

  2021cites this paper
• Immunopathology and Immunotherapy of Central Nervous System Cancer

  2020cites this paper
• Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL

  2019cites this paper
• The role of caveolin-1 in tumors of the brain - functional and clinical implications

  2019cites this paper
• Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Inverse expression of caveolin-1 and EGFR in thyroid cancer patients.

  2017cites this paper
• Investigating therapies in ependymoma

  2016cites this paper
• Prognostic role of epithelial caveolin-1 in cancer : a meta-analysis

  2016cites this paper
• Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients

  2016cites this paper
• Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma

  2016cites this paper
• Recent advances and future of immunotherapy for glioblastoma

  2016cites this paper
• Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers

  2015cites this paper
• Caveolin and cavin family members: dual roles in cancer.

  2014cites this paper
• Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)

  2014cites this paper
• Caveolin-1 as a promoter of tumour spreading: when, how, where and why

  2013cites this paper
• Current and evolving knowledge of prognostic factors for pediatric ependymomas.

  2013cites this paper
• Molecular approaches to ependymoma: the next step(s).

  2012cites this paper
• Caveolin-1 in Brain Tumors

  2012cites this paper
• Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme

  2012cites this paper